Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
BMC Cancer|December 21, 2022
HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathwaysXin Nie, Dawo Liu, Mingjun Zheng, et al.Journal of Translational Medicine|September 3, 2019
Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of AnnexinsRui Gou, Liancheng Zhu, Mingjun Zheng, et al.Pediatric Blood & Cancer|April 11, 2022
Upregulated YAP promotes oncogenic CTNNB1 expression contributing to molecular pathology of hepatoblastomaSongxian Lu, Min Jiang, Qi Chen, et al.Life Sciences|October 15, 2019
TMEFF2 is a novel prognosis signature and target for endometrial carcinomaLingling Gao, Xin Nie, Mingjun Zheng, et al.American Journal of Translational Research|October 12, 2020
Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validationYuexin Hu, Mingjun Zheng, Caixia Wang, et al.Genomics|April 12, 2021
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancerYuexin Hu, Mingjun Zheng, Shuang Wang, et al.The International Journal of Biochemistry & Cell Biology|September 25, 2019
Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancerLingling Gao, Mingjun Zheng, Qian Guo, et al.International Immunopharmacology|March 26, 2022
Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosisXin Nie, Mingjun Zheng, Lingling Gao, et al.Aging|July 2, 2019
Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinomaMingjun Zheng, Yuexin Hu, Rui Gou, et al.Frontiers in Oncology|July 19, 2021
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related GenesRui Gou, Yuexin Hu, Ouxuan Liu, et al.Pageof 5